Incyte
INCY
#1110
Rank
C$27.80 B
Marketcap
C$141.63
Share price
2.05%
Change (1 day)
34.82%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of September 2025 : C$6.42 Billion

According to Incyte's latest financial reports the company has C$6.42 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$4.94 B-28.13%
2023-12-31$C$6.88 B16.08%
2022-12-31$C$5.93 B23.42%
2021-12-31$C$4.80 B44.3%
2020-12-31$C$3.32 B-1.89%
2019-12-31$C$3.39 B29.35%
2018-12-31$C$2.62 B27.97%
2017-12-31$C$2.05 B263.69%
2016-12-31$C$0.56 B137.42%
2015-12-31$C$0.23 B-350.64%
2014-12-31$-C$94.73 Million-53.92%
2013-12-31$-C$0.21 Billion18.16%
2012-12-31$-C$0.18 Billion-24.68%
2011-12-31$-C$0.24 Billion160.68%
2010-12-31$-C$88.61 Million-17.75%
2009-12-31$-C$0.11 Billion-59.86%
2008-12-31$-C$0.27 Billion68.67%
2007-12-31$-C$0.16 Billion60.97%
2006-12-31$-C$98.86 Million337.76%
2005-12-31$-C$22.59 Million-123.95%
2004-12-31$C$94.3 M-52.89%
2003-12-31$C$0.20 B-58.08%
2002-12-31$C$0.47 B-31.89%
2001-12-31$C$0.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
C$13.28 B 106.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$1.31 B-79.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$32.94 B 412.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 1,901.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$0.34 B-94.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.21 B-96.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$61.82 B 862.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
C$39.84 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$35.02 Million-100.54%๐Ÿ‡บ๐Ÿ‡ธ USA